Highbridge Capital Management’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
LP
BG
Highbridge Capital Management's AGN Position: Q4 2018 in Review
Highbridge Capital Management sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 14,055 shares — an estimated $2.68M sold.
Highbridge Capital Management first reported a position in AGN in Q2 2013 and held it in 15 quarters. The position peaked at $43.5M in Q3 2017. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.
- Highbridge Capital Management reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
- Highbridge Capital Management sold 14,055 Allergan plc shares in Q4 2018, an estimated $2.68M.
- Highbridge Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 15 quarters.
- Highbridge Capital Management's Allergan plc position peaked at $43.5M in Q3 2017.
- 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.
Based on Highbridge Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.